<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
 <head>
 </head>
 <body>
  <h1>
   Ranbaxy Pharmaceuticals Inc.
  </h1>
  <div style="display: none;">
   <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <thead>
     <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
     </tr>
    </thead>
    <tbody>
     <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
        937890044
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       132804
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
     </tr>
    </tbody>
   </table></div><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" /><p>
   Ranbaxy Pharmaceuticals (RPI) is in a real no-name business. The company, the US arm of Indian generic pharmaceuticals giant
   <company id="132779">
    Ranbaxy Laboratories Limited
   </company>
   , makes and markets dozens of generic and over-the-counter (OTC) drugs. RPI's generic offerings, produced by manufacturing subsidiary Ohm Laboratories, include anti-infectives and treatments for cardiovascular, gastrointestinal, and central nervous system disorders. Its OTC products include analgesics, antihistamines, and decongestants. Sister subsidiary Ranbaxy Laboratories, Inc. (RLI) develops branded pharmaceuticals.
  </p><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Operations.flsnp" />
  <p>
   RPI continues to have several new drug applications approved by the FDA each year, with a pipeline of therapies pending approval. The company's branded business in the US is currently based on dermatological and anti-diabetes products and includes such brands as Pernox for acne and Sebulex for dandruff.
  </p>
  <p>
   Ohm Laboratories manufactures RPI's generic and OTC products. Among the products fabricated there are caplets, capsules, and tablets in the categories of analgesics, allergy and cold treatments, antacids, anti-diarrheals, and laxatives. Ohm also provides private-label and contract manufacturing services.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Strategy.flsnp" />
  <p>
   RPI pursues growth through organic R&amp;D efforts, acquisitions, and licensing and partnership agreements. RPI has a partnership with Zenotech Laboratories for the development of a number of oncology-related treatments. Parent firm Ranbaxy owns about half of Zenotech Laboratories. The company also partners with
   <company id="155220">
    Validus Pharmaceuticals
   </company>
   for a generic version of calcium drug Rocaltrol (calcitriol).
  </p>
  <p>
   RPI also licensed the generic form of type II diabetes medication Actos from
   <company id="56037">
    Takeda Pharmaceuticals
   </company>
   following a lengthy court battle over the drug's patent. Under terms of the licensing deal, RPI can launch the generic version of the drug, called pioglitazone, in the US beginning in 2012.
  </p>
 <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /></body>
</html>
